Ipca Laboratories Brand Guidelines: Mumbai 1949, Ratlam APIs & a 2023 Unichem Stake

A Bombay company of 1949.

Ipca Laboratories was incorporated in Mumbai, then Bombay, on 19 October 1949 as The Indian Pharmaceutical Combine Association Limited, founded by a group of businessmen and medical professionals, English Wikipedia says. It took its present name, Ipca Laboratories, in 1964, commissioned a manufacturing plant in Mumbai in 1969 and began marketing its own formulations in India in 1976, according to the same article. The company itself says it has been making medicines “since 1949.”

The turning point came in 1975, when control of what English Wikipedia describes as a loss-making company passed to a group that included the chartered accountant Premchand Godha and members of the Bachchan family, among them the film actor Amitabh Bachchan. Medical Dialogues, reporting in February 2025, also described Ipca as a struggling unit when it was taken over in 1975. Godha joined the board that October and became managing director in 1983.

The next decade set the shape of the company. Ipca commissioned its first API plant at Ratlam, in Madhya Pradesh, in 1984, and became a public limited company in 1993, English Wikipedia says. The Bachchan family then sold out: English Wikipedia says a sale of its holding to Ipca’s whole-time directors was agreed in 1997 and that the family had left by 1999, while Medical Dialogues gave the exit year as 1998. The Godha family has led the company since, and a 2023 note on the Competition Commission of India’s review of the Unichem deal, published by the law firm AZB & Partners, put the family’s shareholding at about 36.7 percent.

Formulations and their ingredients.

Ipca makes both finished medicines and the active pharmaceutical ingredients, or APIs, that go into them. English Wikipedia counts more than 350 formulations and around 80 APIs, in therapeutic areas including pain management, rheumatology, antimalarials and cardiovascular medicine. Medical Dialogues named Zerodol, for arthritis pain, and Lariago, an antimalarial, as flagship brands in 2025. On the ingredient side, Ipca describes itself as one of the world’s largest suppliers of several APIs, among them atenolol, losartan and hydroxychloroquine sulphate, English Wikipedia reports.

The company has grown through purchases abroad and at home. According to English Wikipedia, it bought Onyx Scientific, a contract development and manufacturing business in Sunderland in the United Kingdom, in 2011; agreed in 2013 to take half of Avik Pharmaceutical, a Vapi maker of steroid and hormone APIs; and in January 2018 bought Pisgah Laboratories, an API contract manufacturer in North Carolina. In 2014 it entered biosimilars through an alliance with the US biotechnology firm Oncobiologics.

The largest step came in 2023. On 24 April 2023 Business Today reported that Ipca had signed a share purchase agreement for about a third of Unichem Laboratories, a Mumbai drugmaker that English Wikipedia says was founded in 1944, and would make an open offer for up to 26 percent more. Ipca notified the Competition Commission of India on 18 May 2023, and the commission approved the deal subject to voluntary modifications, AZB & Partners wrote on 27 October 2023. English Wikipedia says the purchase was completed in August 2023 and that the open offer took Ipca’s holding to 52.67 percent, bringing Unichem’s subsidiaries in the United States, Europe and elsewhere into the group.

Most manufacturing is in India. English Wikipedia lists 16 Indian units across Madhya Pradesh, Gujarat, Maharashtra, Uttarakhand, Sikkim and Dadra and Nagar Haveli, plus Onyx in Britain and Pisgah in the United States. In February 2025 Medical Dialogues reported plans for a 700-acre site at Hingni in Maharashtra’s Wardha district, with a 15-megawatt solar plant and boilers fired by agricultural-waste pellets instead of coal, to make chloroquine tablets, injections and syrups.

Design and documentation.

India’s drug makers are spread across several states, and some regions have become clusters. English Wikipedia’s article on the pharmaceutical industry in Gujarat calls Ahmedabad and Vadodara the state’s pharmaceutical hubs and records that the state government declared Gujarat a “pharma hub” in 2000; Torrent Pharma’s plants at Chhatral and Dahej are in the same state. Glenmark’s August 2026 factsheet lists formulation plants in Goa, Sikkim, Madhya Pradesh, Himachal Pradesh and Maharashtra, as well as in Argentina, the United States and the Czech Republic.

Many of the companies in this guide began as family firms and still carry their founders’ stories. Glenmark’s name, English Wikipedia says, was made from the names of its founder’s two sons; Torrent Pharma started in 1959 as Trinity Laboratories and belongs to a group that also runs power and gas businesses. Where a company’s history rests only on its own website, this guide says so.

The industry has its own meeting places. CPHI India, the Informa trade fair that bills itself as “the heart of South Asia’s pharma,” runs from 23 to 26 November 2026 at the IICC in Delhi, alongside the PMEC India machinery show at Greater Noida, according to its website. DCAT Week, which calls itself “the premier event for the global bio/pharmaceutical business ecosystem,” is next held in New York City from 15 to 18 March 2027.

This guide looks at how each company presents itself — in plant photographs, laboratory imagery, packs, founder portraits and corporate colours — and sets out what can be checked about each one: who founded it, who owns it and where it says its medicines are made, marking clearly what rests only on the company’s own word.

A warning letter, and a return to the US market.

Ipca’s record with the US Food and Drug Administration is part of its recent history. English Wikipedia says the FDA placed the Ratlam API plant under an import alert in January 2015 and extended import alerts to the formulation plants at Pithampur and Piparia, in Silvassa, in March 2015. On 29 January 2016 the FDA’s drugs centre issued a warning letter covering all three plants, its first good-manufacturing-practice warning letter of that year, the FDA Law Blog reported on 15 February 2016; the letter described what investigators called “systemic data manipulation.” English Wikipedia says the import alerts were lifted in 2023 after fresh inspections, that the Ratlam plant’s June 2023 inspection was classified “voluntary action indicated” that October, and that Ipca has since resumed selling formulations in the United States through Unichem’s American subsidiary.

Today Ipca Laboratories is listed on the BSE and the National Stock Exchange of India, headquartered in Mumbai and led by the Godha family, with Unichem as its majority-owned subsidiary.

For a design guide, Ipca Laboratories shows how a long formal name can shrink to a short one and outlast changes of control. Compare Cipla, another drugmaker founded in Bombay, and Zydus, which began as Cadila in 1952. For this guide we use an indigo, a slate and an ochre with a serif, an unofficial interpretation; no product or logo is reproduced.

Keep Ipca Laboratories’s identity on hand — save it to a board in the Made Good inspiration library.